Alvotech (ALVO)

NASDAQ: ALVO · Real-Time Price · USD

9.19

+0.26 (2.91%)

At close: Jul 3, 2025, 1:00 PM

9.16

-0.03 (-0.32%)

After-hours: Jul 3, 2025, 2:25 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biosimilar Medicines	91.43M	Log In
Biosimilar Medicines Growth	10.12%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Europe	63.51M	Log In
Europe Growth	61.06%	Log In
North America	18.31M	Log In
North America Growth	-40.53%	Log In
Asia and Other	9.62M	Log In
Asia	-	Log In
Other	-	Log In